Trial · NCT02674464
Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)
NCT02674464, Not applicable, Completed, Johns Hopkins University; results first posted 2022-07-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project). Trials, record NCT02674464. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02674464
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)
- NCT number
- NCT02674464
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,820 participants, actual
- Lead sponsor
- Johns Hopkins University
- Conditions
- Uncontrolled Hypertension
- Interventions
Provider Audit-Feedback, Stratified by Race and Ethnicity, Blood Pressure Measurement Standardization, System Level Leadership Intervention, Collaborative Care Team Intervention, Community Health Worker Referral, Specialist Care Consultation
- First posted
- 2016-02-04
- Last updated
- 2022-07-01
- Results first posted
- 2022-07-01
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Controlled Blood Pressure | 12 months | Number of participants with Controlled Blood Pressure (\<140/90 mm Hg). |
| Primary | Patient Activation Measure (PAM-13) | Baseline, 12 months | The Patient Activation Measure assesses knowledge, skills, and confidence in the management of one's health. It is comprised of 13 items and each item is on a 1-5 scale. Insignia health scores on a standardized overall score of 0-100 where higher scores indicate a better outcome. |
| Secondary | Mean Systolic Blood Pressure | Baseline, 12 months | Mean Systolic Blood Pressure in mm Hg at baseline and 12 months. |
| Secondary | Mean Diastolic Blood Pressure | Baseline, 12 months | Mean Diastolic Blood Pressure in mm Hg at baseline and 12 months. |
| Secondary | Change in Global Framingham Risk Score | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean Total Cholesterol (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean LDL-C (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean HDL (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | % With Controlled Total Cholesterol | Baseline | Clinical Outcome |
| Secondary | % With Controlled Total Cholesterol | 12 months | Clinical Outcome |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Controlled Blood Pressure | 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Patient Activation Measure (PAM-13) | Baseline, 12 months | 790 patients in the SCP arm completed the follow-up survey at 12-months, but 1 patient did not complete the PAM-13 (primary patient-reported outcome) questions in the survey resulting in 789 patients in the sample. 733 patients in the CC/SC arm competed the follow-up survey at 12-months, but 2 patients did not complete the PAM-13 (primary patient-reported outcome) questions in the survey resulting in 731 patients in the sample. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Mean Systolic Blood Pressure | Baseline, 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | mm Hg | LEAST_SQUARES_MEAN |
| SECONDARY | Mean Diastolic Blood Pressure | Baseline, 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | mm Hg | LEAST_SQUARES_MEAN |
| SECONDARY | Change in Global Framingham Risk Score | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean Total Cholesterol (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean LDL-C (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean HDL (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | % With Controlled Total Cholesterol | Baseline | |||
| SECONDARY | % With Controlled Total Cholesterol | 12 months |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 outcomesResults by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Controlled Blood Pressure | Standard of Care Plus (SCP) | 462 | Participants | ||
| Number of Participants With Controlled Blood Pressure | Collaborative Care/Stepped Care (CC/SC) | 442 | Participants | ||
| Patient Activation Measure (PAM-13) | Standard of Care Plus (SCP) | Baseline | 65.4 | 95% Confidence Interval 63.4 to 67.4 | score on a scale |
| Patient Activation Measure (PAM-13) | Collaborative Care/Stepped Care (CC/SC) | Baseline | 66.1 | 95% Confidence Interval 64.6 to 68.7 | score on a scale |
| Patient Activation Measure (PAM-13) | Standard of Care Plus (SCP) | 12 months | 66.7 | 95% Confidence Interval 64.6 to 68.7 | score on a scale |
| Patient Activation Measure (PAM-13) | Collaborative Care/Stepped Care (CC/SC) | 12 months | 67.9 | 95% Confidence Interval 65.8 to 70.0 | score on a scale |
| Mean Systolic Blood Pressure | Standard of Care Plus (SCP) | Baseline | 151.8 | 95% Confidence Interval 150.3 to 153.3 | mm Hg |
| Mean Systolic Blood Pressure | Collaborative Care/Stepped Care (CC/SC) | Baseline | 152.5 | 95% Confidence Interval 151.0 to 154.0 | mm Hg |
| Mean Systolic Blood Pressure | Standard of Care Plus (SCP) | 12 months | 137.1 | 95% Confidence Interval 135.5 to 138.7 | mm Hg |
| Mean Systolic Blood Pressure | Collaborative Care/Stepped Care (CC/SC) | 12 months | 138.7 | 95% Confidence Interval 137.1 to 140.2 | mm Hg |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 results by groupParticipant flow8
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard of Care Plus | 927 | 15 |
| Overall Study | STARTED | Collaborative Care/Stepped Care (CC/SC) | 893 | 15 |
| Overall Study | 6 Month Follow-up | Standard of Care Plus | 771 | 15 |
| Overall Study | 6 Month Follow-up | Collaborative Care/Stepped Care (CC/SC) | 806 | 15 |
| Overall Study | COMPLETED | Standard of Care Plus | 790 | 15 |
| Overall Study | COMPLETED | Collaborative Care/Stepped Care (CC/SC) | 733 | 15 |
| Overall Study | NOT COMPLETED | Standard of Care Plus | 137 | 0 |
| Overall Study | NOT COMPLETED | Collaborative Care/Stepped Care (CC/SC) | 160 | 0 |
Source ClinicalTrials.gov
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Self-reported stroke | Cardiac disorders | Standard of Care Plus (SCP) | 22 | 875 | |
| other | Self-reported stroke | Cardiac disorders | Collaborative Care/Stepped Care (CC/SC) | 24 | 835 | |
| other | Myocardial infarction | Cardiac disorders | Standard of Care Plus (SCP) | 9 | 875 | |
| other | Myocardial infarction | Cardiac disorders | Collaborative Care/Stepped Care (CC/SC) | 19 | 835 | |
| other | Fall precipitating medical treatment | General disorders | Standard of Care Plus (SCP) | 84 | 875 | |
| other | Fall precipitating medical treatment | General disorders | Collaborative Care/Stepped Care (CC/SC) | 82 | 835 | |
| other | Hospitalizations | General disorders | Standard of Care Plus (SCP) | 227 | 875 | |
| other | Hospitalizations | General disorders | Collaborative Care/Stepped Care (CC/SC) | 212 | 835 | |
| other | Hypotension | Cardiac disorders | Standard of Care Plus (SCP) | 197 | 873 | |
| other | Hypotension | Cardiac disorders | Collaborative Care/Stepped Care (CC/SC) | 186 | 842 |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard of Care Plus (SCP) | 21 | 927 |
| Total, all-cause mortality | Collaborative Care/Stepped Care (CC/SC) | 34 | 893 |
| Total, other adverse events | Standard of Care Plus (SCP) | 515 | 927 |
| Total, other adverse events | Collaborative Care/Stepped Care (CC/SC) | 499 | 893 |
| Total, serious adverse events | Standard of Care Plus (SCP) | 0 | 927 |
| Total, serious adverse events | Collaborative Care/Stepped Care (CC/SC) | 0 | 893 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| UH3HL130688 | Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities | COOPER, LISA A; MARSTELLER, JILL ANNE | JOHNS HOPKINS UNIVERSITY | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE | 2016 to 2019 |
Source NIH RePORTER
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Standard of Care Plus (SCP) vs Collaborative Care/Stepped Care (CC/SC): Number of Participants With Controlled Blood Pressure | Trial comparisons |
| Standard of Care Plus (SCP) vs Collaborative Care/Stepped Care (CC/SC): deaths from any cause | Trial comparisons |
| Standard of Care Plus (SCP) vs Collaborative Care/Stepped Care (CC/SC): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02674464
GET https://conductscience.org/api/trials/v1/NCT02674464/registered?page=2